BiOrigin ApS - CVR: 38734164

2023, DKK

05.04.2024

Bruttoresultat

2.876'

Primær drift

-14.610'

Årets resultat

-11.228'

Aktiver

14.614'

Kortfristede aktiver

13.609'

Egenkapital

10.260'

Afkastningsgrad

-100 %

Soliditetsgrad

70 %

Likviditetsgrad

317 %

Resultat

05.04.2024

Årsrapport	2023 05.04.2024	2022 08.05.2023	2021 23.06.2022	2020 08.07.2021	2019 18.08.2020	2018 31.05.2019	2017 22.05.2018
Nettoomsætning		5.849.077	2.026.890	1.651.840	1.159.899	1.054.588	225.706
Bruttoresultat	2.876.436	0	0	0	0	0	0
Resultat af primær drift	-14.609.721	-7.702.525	-3.567.351	-3.993.238	-2.740.990	-2.693.521	-376.998
Indtægter af kapitalandele (tilknyttede og associerede)	0	0	0	0	0	0	0
Finansielle indtægter	174.153	11.099	646	37.927	52	7.951	0
Finansieringsomkostninger	0	0	0	0	0	0	0
Andre finansielle omkostninger	-16.780	-21.549	-60.748	-30.648	-13.527	-92	-8.002
Resultat før skat	-14.452.348	-7.712.975	-3.627.453	-3.985.959	-2.754.465	-2.685.662	-385.000
Resultat	-11.228.030	-6.017.830	-2.829.711	-3.109.048	-2.148.483	-2.094.816	-300.300
Forslag til udbytte	0	0	0	0	0	0	0

Aktiver

05.04.2024

Årsrapport	2023 05.04.2024	2022 08.05.2023	2021 23.06.2022	2020 08.07.2021	2019 18.08.2020	2018 31.05.2019	2017 22.05.2018
Kortfristede varebeholdninger	0	0	0	0	0	0	0
Kortfristede tilgodehavender fra salg og tjenesteydelser	6.282.339	3.336.144	1.107.079	1.942.941	885.524	715.200	131.625
Likvider	7.326.373	9.393.511	6.645.753	9.001.245	5.555.574	3.606.225	2.741.206
Kortfristede aktiver	13.608.712	12.729.655	7.752.832	10.944.186	6.441.098	4.321.425	2.872.831
Immaterielle aktiver og goodwill	0	0	0	0	0	0	0
Finansielle anlægsaktiver	10.899	41.520	16.293	16.293	16.293	15.818	0
Materielle aktiver	994.202	769.174	0	0	0	0	0
Langfristede aktiver	1.005.101	810.694	16.293	16.293	16.293	15.818	0
Aktiver	14.613.813	13.540.349	7.769.125	10.960.479	6.457.391	4.337.243	2.872.831

Aktiver

05.04.2024

Passiver

05.04.2024

Årsrapport	2023 05.04.2024	2022 08.05.2023	2021 23.06.2022	2020 08.07.2021	2019 18.08.2020	2018 31.05.2019	2017 22.05.2018
Forslag til udbytte	0	0	0	0	0	0	0
Egenkapital	10.260.070	10.488.100	6.505.930	9.335.641	5.444.689	3.604.884	2.699.700
Hensatte forpligtelser	60.772	40.952	0	0	0	0	0
Langfristet gæld til banker	0	0	0	0	0	0	0
Anden langfristet gæld		0	499.519	489.744	158.894	0	0
Leverandører af varer og tjenesteydelser	1.116.369	1.954.431	346.505	182.474	325.238	259.748	14.048
Kortfristede forpligtelser	4.292.971	3.011.297	763.676	1.135.094	853.808	732.359	173.131
Gældsforpligtelser	4.292.971	3.011.297	1.263.195	1.624.838	1.012.702	732.359	173.131
Forpligtelser	4.292.971	3.011.297	1.263.195	1.624.838	1.012.702	732.359	173.131
Passiver	14.613.813	13.540.349	7.769.125	10.960.479	6.457.391	4.337.243	2.872.831

Passiver

05.04.2024

Nøgletal

05.04.2024

Årsrapport	2023 05.04.2024	2022 08.05.2023	2021 23.06.2022	2020 08.07.2021	2019 18.08.2020	2018 31.05.2019	2017 22.05.2018
Afkastningsgrad	-100,0 %	-56,9 %	-45,9 %	-36,4 %	-42,4 %	-62,1 %	-13,1 %
Dækningsgrad	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Resultatgrad	Na.	-102,9 %	-139,6 %	-188,2 %	-185,2 %	-198,6 %	-133,0 %
Varelagerets omsætningshastighed	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Egenkapitals-forretning	-109,4 %	-57,4 %	-43,5 %	-33,3 %	-39,5 %	-58,1 %	-11,1 %
Payout-ratio	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Gældsdæknings-nøgletal	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Soliditestgrad	70,2 %	77,5 %	83,7 %	85,2 %	84,3 %	83,1 %	94,0 %
Likviditetsgrad	317,0 %	422,7 %	1.015,2 %	964,2 %	754,4 %	590,1 %	1.659,3 %

Resultat

05.04.2024

Gæld

05.04.2024

Årsrapport

05.04.2024

Nyeste:01.01.2023- 31.12.2023(offentliggjort: 05.04.2024)

Information om virksomhedens regnskabsklasse:The annual report of BiOrigin ApS for 2023 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to reporting class B entities and elective choice of certain provisions applying to reporting class C entities.

Beretning

05.04.2024

Dato for ledelsens godkendelse af årsrapporten:2024-03-21

Statement by Management on the annual report

Identifikation af den godkendte årsrapport:Today, the Board of Directors and the Executive Board have discussed and approved the annual report of BiOrigin ApS for the financial year 1 January - 31 December 2023.

Management's review

Beskrivelse af virksomhedens væsentligste aktiviteter:BiOrigin ApS' (the "Company") primary activity consists of rendering strategic and operational support to the establishment and management of early-stage life sciences companies, primarily within the Novo Holdings’ Seed Investments portfolio, to help them steer through the critical start-up and subsequent growth phase. The Company is fully owned by Novo Holdings A/S. In 2023, the Company continued to grow the number of Entrepreneurs in Residence in order to accelerate company creation and value creation in the portfolio. BiOrigin Labs (renamed to SeedLabs) was expanded and continued its operations of identifying more compelling technologies and to validate and accelerate new therapeutic concepts.